A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

NCT07172516 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder
Bipolar Depression
Bipolar I Disorder
Bipolar II Disorder

Interventions

DRUG: Azetukalner
DRUG: Placebo

Sponsor

Xenon Pharmaceuticals Inc.